Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer’s Disease
This study has been completed.
Study NCT00100282 Information provided by PRAECIS Pharmaceuticals Inc.
First Received on December 27, 2004. Last Updated on September 18, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Nervous System Diseases
Interventions listed in this trial
Sponsors listed in this trial
PRAECIS Pharmaceuticals Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers